Andy Teng

Title: Innovations by Andy Teng in Nucleic Acid Cloning

Introduction

Andy Teng is an accomplished inventor based in Fullerton, California. He has made significant contributions to the field of genetic engineering, particularly in the area of nucleic acid cloning. His innovative methods have the potential to streamline genetic research and applications.

Latest Patents

Andy Teng holds a patent for a method titled "Rapid and enzymeless cloning of nucleic acid fragments." This patent describes a technique for cloning a nucleic acid fragment into a vector by flanking the fragment with first and second adapter sequences. The method involves contacting the fragment with a vector that has sequences homologous to the adapter sequences, allowing for the incorporation of the nucleic acid fragment into the vector through homologous recombination in vivo within a host cell. Additionally, the patent outlines a method for selecting successful transformations of a vector by a nucleic acid insert. It also includes systems for cloning a nucleic acid fragment into a vector without the use of restriction enzymes, ligases, gyrases, single-stranded DNA binding proteins, or other DNA-modifying enzymes. Furthermore, a kit for cloning a nucleic acid fragment into a vector is also part of his patent.

Career Highlights

Andy Teng is currently associated with Gene Therapy Systems, Inc., where he continues to advance his research and innovations. His work has garnered attention for its potential applications in gene therapy and biotechnology.

Collaborations

Andy has collaborated with notable colleagues, including Xiaowu Liang and Shizhong Chen, who contribute to the innovative environment at Gene Therapy Systems, Inc.

Conclusion

Andy Teng's contributions to nucleic acid cloning represent a significant advancement in genetic engineering. His patented methods and ongoing work at Gene Therapy Systems, Inc. highlight his role as a key innovator in the field.